Stephens Issues Pessimistic Forecast for Definitive Healthcare (NASDAQ:DH) Stock Price

Definitive Healthcare (NASDAQ:DH) had its price target dropped by research analysts at Stephens from $3.00 to $2.00 in a research note issued to investors on Friday,Benzinga reports. The firm currently has an “equal weight” rating on the stock. Stephens’ price objective would indicate a potential upside of 68.49% from the stock’s previous close.

A number of other research analysts have also recently commented on DH. Canaccord Genuity Group reduced their price objective on Definitive Healthcare from $5.00 to $4.00 and set a “hold” rating on the stock in a research note on Monday, November 10th. Morgan Stanley reissued an “underperform” rating and set a $3.50 price target on shares of Definitive Healthcare in a research report on Thursday, December 18th. Weiss Ratings restated a “sell (d-)” rating on shares of Definitive Healthcare in a report on Wednesday, January 21st. William Blair upgraded shares of Definitive Healthcare to a “strong-buy” rating in a research note on Thursday, November 6th. Finally, Barclays reduced their target price on shares of Definitive Healthcare from $3.00 to $2.75 and set an “underweight” rating on the stock in a research report on Monday, December 8th. One analyst has rated the stock with a Strong Buy rating, one has given a Buy rating, four have issued a Hold rating and three have issued a Sell rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $3.66.

Definitive Healthcare Trading Down 15.2%

Shares of Definitive Healthcare stock traded down $0.21 during trading hours on Friday, hitting $1.19. The company’s stock had a trading volume of 240,918 shares, compared to its average volume of 369,506. The company has a quick ratio of 1.60, a current ratio of 1.60 and a debt-to-equity ratio of 0.41. The company has a market capitalization of $167.79 million, a PE ratio of -0.72 and a beta of 1.59. The business has a fifty day moving average of $2.21 and a 200 day moving average of $2.89. Definitive Healthcare has a 1-year low of $1.14 and a 1-year high of $4.70.

Hedge Funds Weigh In On Definitive Healthcare

Large investors have recently modified their holdings of the stock. State of Alaska Department of Revenue increased its holdings in Definitive Healthcare by 109.3% in the fourth quarter. State of Alaska Department of Revenue now owns 11,433 shares of the company’s stock valued at $32,000 after buying an additional 5,970 shares during the last quarter. Raymond James Financial Inc. acquired a new position in shares of Definitive Healthcare in the 2nd quarter worth approximately $32,000. Schonfeld Strategic Advisors LLC acquired a new position in shares of Definitive Healthcare in the 4th quarter worth approximately $35,000. Savant Capital LLC acquired a new stake in shares of Definitive Healthcare during the 2nd quarter valued at approximately $45,000. Finally, SG Americas Securities LLC bought a new position in Definitive Healthcare during the fourth quarter worth $46,000. Institutional investors own 98.67% of the company’s stock.

Key Definitive Healthcare News

Here are the key news stories impacting Definitive Healthcare this week:

• Positive Sentiment: Balance-sheet improvement — cash and cash equivalents rose to ~$163.6M (up ~55% YoY) and total liabilities fell materially, which supports liquidity and runway. Read More.
• Neutral Sentiment: Revenue was roughly in line with forecasts — Q4 revenue reported at ~$61.5M, slightly above consensus, and adjusted EPS of $0.06 matched analysts’ estimates. This limited upside from the print itself. Read More.
• Neutral Sentiment: Analyst sentiment remains muted — brokerages’ average recommendation is “Hold,” implying limited near-term analyst-driven upside. Read More.
• Negative Sentiment: Guidance cut — management lowered Q1 and FY2026 guidance (Q1 EPS guide ~ $0.03 vs. ~$0.05 consensus; FY EPS guide $0.14–$0.17 vs. ~$0.21 consensus; revenue ranges also below Street), which is the principal driver of the stock’s weakness. Read More.
• Negative Sentiment: GAAP profitability and operating cash flow concerns plus institutional selling — reports show a wider operating loss, a GAAP net loss/diluted EPS weakness (reported by third parties) and a sharp drop in cash from operations; several large institutional holders trimmed positions. These factors amplify downside risk. Read More.

About Definitive Healthcare

Definitive Healthcare (NASDAQ:DH) is a leading provider of intelligence and analytics on healthcare providers, organizations and the professionals who treat patients. Through its cloud-based platform, the company aggregates data from multiple sources—including claims, government registries, commercial filings and proprietary research—to deliver a unified view of the healthcare landscape. Its solutions enable life sciences companies, healthcare providers, payers and consulting firms to identify market opportunities, optimize sales and marketing efforts, improve operational efficiency and support better patient outcomes.

The company’s flagship offering is a subscription-based data platform that features detailed profiles on physicians, hospitals, health systems and post-acute care facilities.